Elena Usova, Alexey Yakovlev, Georgy Kopanitsa, Oleg Metsker, Madina Alieva, Tatiana Makarova, Lev Malishevskii, Ekaterina Murashko, Elizaveta Kessenikh, Sergey Trusov, Asiiat Alieva, Alexandra Konradi
{"title":"Prognostic Value of Ceramide Dynamics in Patients with Acute Coronary Syndrome.","authors":"Elena Usova, Alexey Yakovlev, Georgy Kopanitsa, Oleg Metsker, Madina Alieva, Tatiana Makarova, Lev Malishevskii, Ekaterina Murashko, Elizaveta Kessenikh, Sergey Trusov, Asiiat Alieva, Alexandra Konradi","doi":"10.3233/SHTI241087","DOIUrl":null,"url":null,"abstract":"<p><p>A dynamic study of ceramide concentrations and their association with recurrent event risk could enhance our understanding of cardiovascular complications. To assess the prognostic value of ceramide concentrations (Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:1), Cer(d18:1/24:0)) and their dynamics in combination with standard clinical and laboratory parameters and therapeutic interventions in ACS patients. Among 110 ACS patients, triple blood sampling was performed for targeted lipidomic analysis using high-performance liquid chromatography-tandem mass spectrometry. All ceramide concentrations peaked at admission and decreased by the 3rd day of hospitalization and at the 3-month follow-up. The difference between Cer(d18:1/18:0) concentration 3 months after hospital discharge and its baseline value on admission was strongly associated with recurrent events, independent of prior statin treatment. The association of the Cer(d18:1/18:0) change from 3rd day of hospitalization and its baseline concentration on admission with prognosis varied depending on the glycemic profile.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"175-179"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Studies in health technology and informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/SHTI241087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A dynamic study of ceramide concentrations and their association with recurrent event risk could enhance our understanding of cardiovascular complications. To assess the prognostic value of ceramide concentrations (Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:1), Cer(d18:1/24:0)) and their dynamics in combination with standard clinical and laboratory parameters and therapeutic interventions in ACS patients. Among 110 ACS patients, triple blood sampling was performed for targeted lipidomic analysis using high-performance liquid chromatography-tandem mass spectrometry. All ceramide concentrations peaked at admission and decreased by the 3rd day of hospitalization and at the 3-month follow-up. The difference between Cer(d18:1/18:0) concentration 3 months after hospital discharge and its baseline value on admission was strongly associated with recurrent events, independent of prior statin treatment. The association of the Cer(d18:1/18:0) change from 3rd day of hospitalization and its baseline concentration on admission with prognosis varied depending on the glycemic profile.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
